Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; (CSE: $CRFT.C) (CSE: $BLO.C) (TSXV: $KHRN.V) (OTC: $SKDI)
Delta, Kelowna, BC, November 18th, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at https://www.investorideas.com/news/2019/cannabis-potcasts/11181CRFT-BLO-KHRN-SKDI.asp
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today’s podcast we look at a few early announcements.
Pasha Brands Ltd. (CSE: CRFT) (OTC: CRFTF), Canada's largest craft cannabis brand house, last month called for the complete expungements of cannabis records, and a review of post-legalization enforcement. In the wake of raids on the nation's oldest compassion clubs and dispensaries, Pasha is now calling on the federal government to look into new models of medical access.
As legal adult-use is clearly failing to meet the needs of the same cannabis patients being left behind by the medical access program, and as an association of legal cannabis producers calls on the federal government to increase enforcement on brick and mortar and online illicit retailers, Pasha calls on the federal government to instead exempt Canada's earliest medical dispensaries, it's patients, and it's producers from the Cannabis Act, and to conduct a review of the current medical framework.
Several court cases have set precedents in Canada that have been largely ignored by successive governments. The right to access medical cannabis has been well-established by the courts, but this access is lacking. Not all patients who require cannabinoid-based medicine have access to online sales, fixed addresses, credit cards, or the funds required to purchase their medicine. For these reasons and others, the recommendations following both R. v. Smith and Allard v. Canada touted the benefits of storefront access at dispensaries and compassion clubs.
What's more, access to medical cannabis is protected under Section 7 of the Charter of Rights and Freedoms. This access is also meant to include 'protection from delay'. The 2002 Report of the Senate Special Committee on Illegal Drugs found that medical dispensary practices were in line with therapeutic indications, and that moving forward, Health Canada should work with compassion clubs, rather than against them. By the Senate's own recommendations, these outlets should be part of Canada's existing medical cannabis framework.
Pasha supports this petition calling on the federal government to take action on these now 17-year-old recommendations by supporting and encouraging the development of new models of access; to undertake a full review of the current state of medical cannabis access while including the organizations that inspired and impressed the Senate Committee in 2002; and to grant exemptions to medicinal dispensaries, their patients, and suppliers as the review is ongoing.
Pasha has focused on getting existing farmers into the legal adult-use market, but recognizes the need for improved medical access. "The pre- and post-legalization gold rush on both licit, and illicit, sides of the industry has skewed our understanding of what it means to safely access cannabis," says Jamie Shaw, Pasha's Chief Communications and Culture Officer. "The current framework fails patients, and without proper medical access, they are forced to purchase their medicine from the illicit market or go without. We hope that by gaining MP support for this petition, the public will get a chance to remind the federal government that it was medical patients that carved the path that we're on today, and it is they who still bear the brunt of bad policy."
The petition (e-2301) can be read here: https://www.pashabrands.com/petition-to-the-government-of-ca/
Cannabix Technologies Inc. (CSE: BLO) (OTC: BLOZF) developer of marijuana breathalyzer devices for law enforcement and the workplace, reports that engineers have completed assembly of a handheld portable version of the (UBC) THC Breath Analyzer and are preparing the device to build upon promising human tests conducted earlier this year in Kelowna, BC. Over the last several weeks, Company engineers have reduced the size of several components inside the THCBA for a compact handheld device. Cannabix has been conducting extensive lab testing with the new device. The THC Breath Analyzer (“THCBA”) incorporates sensitive microfluidic sensor technology for the detection of ∆9-tetrahydrocannabinol (“THC”) from breath. Furthermore, several software upgrades are being completed to use cloud-based machine learning (ML) techniques to process data more quickly. Initial ML analysis will be performed by experts at UBC. Cannabix is commissioning several additional units in the short term and expects that these devices will be available for broader multi site testing this winter. The Company has made the first pictures of the newly built THCBA available on its website at cannabixtechnologies.com.
Dr. Mina Hoorfar stated, “We have been working hard in collaboration with Cannabix to optimize the device and its components. Our mutual goal continues to be developing an affordable, portable, fast and accurate device for use with a range of potential users.”
Rav Mlait, CEO, stated, “Our team has been working intensely on our devices for the law enforcement and workplace markets. Several additional police, private and government related agencies have been in touch with Cannabix this fall, showing interest in piloting our devices, as marijuana use for recreational and medical purposes is expanding across various jurisdictions in the United States and we have surpassed one year of recreational use across Canada. Furthermore, we are seeing police and others becoming more open to new technologies related to cannabis impairment detection. We are very excited for the additional prospects for the THCBA because of its single stage, direct breath capability, compact portable design and ability to provide results quickly.”
The Company reports that it has improved several components within its FAIMS (field asymmetric waveform ion mobility spectrometry) THC detection device. More recently, engineers have enhanced sample flow conditions within the unit, worked intensely on ion optics and are testing a new multi-plate detector unit. The Company is also pleased to report that it has been testing with both direct breath and breath collection methods using the FAIMS system.
Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQB: KHRNF) announced the official launch of the Company's Kuida brand in the United States. Beginning this Wednesday, November 20, Kuida's line of CBD skincare products will become available for purchase to US consumers at retail, initially in Los Angeles, before a planned expansion in priority US states where sale of hemp-derived CBD is permitted.
In the California market, Kuida will initially be distributed and sold through a partnership with leading lifestyle media and retail brand, Cannabis Now. With a prime flagship location in Los Angeles and an expanding retail network including three planned stores across major US cities, Cannabis Now offers a selection of non-THC health and wellness products in an experiential retail environment designed to educate both experienced and new cannabis consumers. Through an exclusive activation at Cannabis Now's high-traffic Beverly Hills location, the Kuida brand will target an affluent, on-trend audience of beauty and cannabis consumers, influencers, and professionals across Los Angeles as well as the wider US market.
"We are incredibly proud to be the first Colombian brand to introduce legal CBD products in the US market," stated Elsa Navarro, Skin Unit Director of Khiron Life Sciences. "As we enter the United States market and commence sales, we bring proven success in brand building, a scientifically-backed, GMP lab made product, and a powerful branding and marketing campaign that resonates with consumers. As a result, we find ourselves in a strong position to reach consumers and gain market share in the fast-growing US skincare market."
Eugenio Garcia, CEO and Founder at Cannabis Now comments: "At Cannabis Now, we are disrupting the cannabis retail space to introduce first-of-its-kind experiential and education-focused experiences. Khiron shares our commitment to innovation and high-quality products that help improve the consumer experience, and Kuida is an ideal addition to our retail marketplace. We are very excited to share Kuida with our customer base and wide following in the US."
In addition to in-store programming, the Company will also support the retail pop-up and drive sales through a comprehensive marketing campaign spanning mass media, experiential activations, social media, and influencer partnerships. Kuida will further collaborate with Cannabis Now on educational content as well as print and digital advertising, leveraging the brand's media offering to reach its following of 4.2 million US consumers.
The introduction of Kuida in the United States will kick off with a launch event on Wednesday, November 20th at Cannabis Now with the Khiron executive team, beauty experts and lifestyle influencers. Investors are invited to experience Kuida for themselves and to join Khiron Life Sciences as they celebrate this momentous milestone!
Sun Kissed Industries Inc. (OTC:SKDI), an emerging player in the CBD marketplace, announced that its soon-to-be subsidiary, Hakuna Supply/Products Group, Inc., an award-winning CBD-based products company, is releasing for sale its new “Fingerprint Lock Box” biometric sensing storage device for cannabis, hemp, and CBD products in time for the 2019 Holiday Shopping Season.
Sun Kissed and Hakuna are nearing the signing of their Definitive Agreement, by which Sun Kissed will acquire 100% of the issued and outstanding shares of Hakuna, a private CBD products leader booking strong revenues with over 110 established retail distribution partners across more than 20 states in the domestic US market.
“I’m truly excited that the Hakuna acquisition appears set to be finalized sooner than expected as Hakuna continues to roll out powerful new products,” stated Carl Grant, CEO of Sun Kissed. “As we get ready to close the acquisition, our attention will quickly turn toward marketing the many award-winning top-tier products Hakuna has crafted, with this beautiful new state-of-the-art biometric sensing Fingerprint Lock Box representing yet another success story as shoppers get set for the Holiday Season.”
Management notes that the new Hakuna Fingerprint Lock Box sits at the intersection of major market trends, with the biometric sensing market already projected to grow from $3.5 billion in 2019 to $7.1 billion by 2024 at a CAGR of 15.3%, according to recent research from MarketsandMarkets, and overall sales within the legalized U.S. cannabis industry expected to reach $13.6 billion throughout 2019, for a 32% increase over 2018, according to New Frontier data.
The Fingerprint Lock Box is a perfect holiday gift idea, with a sleek and stylish look, and a robust design built to keep products safe and secure behind a lock controlled through a fingerprint-triggered biometric sensing mechanism, with an included back-up metal key for extra assurance. The box can be charged by a USB-compatible, portable, removable wireless charger located at its base.
“We are working closely with Hakuna to provide for a smooth transition as we get set to integrate Hakuna’s operations and prepare to invest in growing the company into one of the biggest CBD players in the US domestic market,” continued Mr. Grant. “That shouldn’t be a stretch given the company’s massive existing distribution footprint and its award-winning product line. We look forward to updating current and prospective shareholders as events transpire.”
Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Cannabis Social Media
Contact Investorideas.com
800-665-0411
